AIM IMMUNOTECH

Welcome to the Brand page for “AIM IMMUNOTECH”, which is offered here for Intravenous solution for use in the treatment of viral infections, immune disorders, cancer and me/cfs; intravenous solution for use in the treatment of viral infections, immune disorders, cancer and me/cfs; intravenous solution for use in the treatment of injuries resulting from surgery, thermal accidents or burns; interferons; parenterally administered interferon for use in treating viral diseases, immunological disorders and cancer; pharmaceutical products, pharmaceutical preparations for treatment of viral and infectious diseases, cancer, immune disorders and me/cfs; intranasal solutions for use as a vaccine adjuvant, all of the foregoing primarily available by prescription;aim immunological tech;pharmaceutical research and development; pharmaceutical research and development of drugs for the treatment of cancers, viral diseases, immunological disorders and me/cfs;.

Its status is currently believed to be active. Its class is unavailable. “AIM IMMUNOTECH” is believed to be currently owned by “AIM IMMUNOTECH INC.”